Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEO in Newly Diagnosed Glioblastoma
NCT04450160Phase 2Unknown
- Sponsor
- MetVital, Inc.
- Start
- Dec 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of oxaloacetate in glioblastoma multiforme (GBM), sponsored by MetVital, Inc.. Status: unknown.
02
Drugs
oxaloacetate
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT04450160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04450160.